Medigen Biotechnology Corp. (TPEX:3176)
Taiwan
· Delayed Price · Currency is TWD 30.75
-0.30 (-0.97%)
Jun 13, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Generic Drug, Aesthetic Medicine Product and Dietary Supplement | 709.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Drug, Aesthetic Medicine Product and Dietary Supplement Growth | 16.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drug and Vaccine Research and Development | 389.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drug and Vaccine Research and Development Growth | 6.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nucleic Acid | 59.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nucleic Acid Growth | -29.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cytotherapy | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cytotherapy Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adjustment and Elimination | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adjustment and Elimination Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Taiwan | 1.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | 14.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 6.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -84.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 4.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | -54.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discontinued Operations | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discontinued Operations Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|